Retrospective observational study of salvage line ramucirumab monotherapy for patients with advanced gastric cancer

BACKGROUND: Ramucirumab monotherapy as a second-line treatment for advanced gastric cancer (AGC) prolongs survival compared to the best supportive care. However, in clinical practice, ramucirumab monotherapy is sometimes used as third- or later-line treatment for AGC refractory to fluoropyrimidine a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawai, Sadayuki, Fukuda, Naoki, Yamamoto, Shun, Mitani, Seiichiro, Omae, Katsuhiro, Wakatsuki, Takeru, Kato, Ken, Kadowaki, Shigenori, Takahari, Daisuke, Boku, Narikazu, Muro, Kei, Machida, Nozomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175590/
https://www.ncbi.nlm.nih.gov/pubmed/32316940
http://dx.doi.org/10.1186/s12885-020-06865-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175590/
https://www.ncbi.nlm.nih.gov/pubmed/32316940
http://dx.doi.org/10.1186/s12885-020-06865-7

Ejemplares similares